These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26520895)

  • 21. Relationship between inflammatory cytokines and uric acid levels with adverse cardiovascular outcomes in patients with stable coronary heart disease.
    Rothenbacher D; Kleiner A; Koenig W; Primatesta P; Breitling LP; Brenner H
    PLoS One; 2012; 7(9):e45907. PubMed ID: 23029307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease.
    Eichinger S; Kyrle PA; Kammer M; Eischer L; Ozsvar Kozma M; Binder CJ
    J Thromb Haemost; 2018 Jan; 16(1):31-35. PubMed ID: 29045005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory response.
    Diepenhorst GM; Ciurana CL; Diaz Padilla N; Boekholdt SM; Krijnen PA; Lagrand WK; Niessen HW; Hack CE
    Adv Clin Exp Med; 2012; 21(4):455-67. PubMed ID: 23240451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
    Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study.
    von Eynatten M; Breitling LP; Roos M; Baumann M; Rothenbacher D; Brenner H
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2327-35. PubMed ID: 22679309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skövde Cohort.
    Daka B; Olausson J; Larsson CA; Hellgren MI; Råstam L; Jansson PA; Lindblad U
    BMC Cardiovasc Disord; 2015 Nov; 15():146. PubMed ID: 26573599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low Levels of Apolipoprotein B-100 Autoantibodies Are Associated With Increased Risk of Coronary Events.
    Björkbacka H; Alm R; Persson M; Hedblad B; Nilsson J; Fredrikson GN
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):765-71. PubMed ID: 26916732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.
    Eldrup N; Kragelund C; Steffensen R; Nordestgaard BG
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):677-83. PubMed ID: 21194909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
    Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Hartley O; Montecucco F; Mach F; Kutalik Z; Waeber G; Vollenweider P; Vuilleumier N
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2342-2349. PubMed ID: 29074586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome.
    Kilic T; Oner G; Ural E; Yumuk Z; Sahin T; Bildirici U; Acar E; Celikyurt U; Kozdag G; Ural D
    Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
    Siegerink B; Maas R; Vossen CY; Schwedhelm E; Koenig W; Böger R; Rothenbacher D; Brenner H; Breitling LP
    Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of circulating leukocyte subtype counts in patients with coronary artery disease.
    Yamamoto E; Sugiyama S; Hirata Y; Tokitsu T; Tabata N; Fujisue K; Sugamura K; Sakamoto K; Tsujita K; Matsumura T; Kaikita K; Hokimoto S
    Atherosclerosis; 2016 Dec; 255():210-216. PubMed ID: 27612676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls.
    Lourdudoss C; Ajeganova S; Frostegård J
    Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of serum immunoglobulin M levels in patients with acute coronary syndrome.
    Qi X; Zhang Y; Wang Y; Sun J; Yang R; Wang S; Dong J; Chen W; Ji F; Yu X
    Atherosclerosis; 2024 Aug; 395():117552. PubMed ID: 38954858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of tissue transglutaminase antibody seropositivity with coronary heart disease: Findings from a prospective cohort study.
    Heikkilä K; Rissanen H; Heliövaara M; Knekt P; Mäki M; Kaukinen K
    Nutr Metab Cardiovasc Dis; 2017 Sep; 27(9):817-821. PubMed ID: 28756971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease.
    Falcone C; Minoretti P; D'Angelo A; Buzzi MP; Coen E; Emanuele E; Aldeghi A; Olivieri V; Geroldi D
    Eur J Clin Invest; 2006 Apr; 36(4):211-7. PubMed ID: 16620281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
    Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
    Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low levels of antibodies against phosphorylcholine in Alzheimer's disease.
    Eriksson UK; Sjöberg BG; Bennet AM; de Faire U; Pedersen NL; Frostegård J
    J Alzheimers Dis; 2010; 21(2):577-84. PubMed ID: 20571218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
    Schindhelm RK; Dekker JM; Nijpels G; Bouter LM; Stehouwer CD; Heine RJ; Diamant M
    Atherosclerosis; 2007 Apr; 191(2):391-6. PubMed ID: 16682043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.